Intrahepatic Cholangiocarcinoma: State of the Art of FGFR Inhibitors

OBJECTIVE: Intrahepatic cholangiocarcinoma (iCCA), the second most common type of primary liver tumor, has an increasing incidence in the past few decades. iCCA is highly malignant, with a 5-year survival rate of approximately 5-10%. Surgical resection is usually the prescribed treatment for patient...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Tianyu, Jiang, Xiaoqing, Zhang, Xin, Wu, Bodeng, Xu, Bin, Liu, Xiaoliu, Zheng, Lei, Wang, Yu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8482710/
https://www.ncbi.nlm.nih.gov/pubmed/33618536
http://dx.doi.org/10.1177/1073274821989314

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8482710/
https://www.ncbi.nlm.nih.gov/pubmed/33618536
http://dx.doi.org/10.1177/1073274821989314

Ejemplares similares